Table 2.
Patient Characteristics Associated With BeLPT Orders Among US Veterans With Sarcoidosis (n = 27,659)
| Variable | Multivariable Logistic Regression OR (95% CI) | P Value |
|---|---|---|
| Embedded fragments | 2.13 (1.01-3.98) | .03 |
| Age (per 10-y increase) | 1.02 (0.88-1.19) | .78 |
| Sex | ||
| Female | Reference | … |
| Male | 1.16 (0.67-2.18) | .62 |
| Race | ||
| White | Reference | … |
| Black | 0.46 (0.31-0.68) | < .001 |
| Other or unknown | 0.51 (0.21-1.03) | .09 |
| Residence by region | ||
| Northeast | Reference | … |
| South | 1.15 (0.68-2.04) | .61 |
| Midwest | 1.38 (0.78-2.53) | .28 |
| West | 1.76 (0.97-3.26) | .06 |
| Branch of service | ||
| Army | Reference | … |
| Air Force | 1.14 (0.69-1.81) | .60 |
| Marines | 1.15 (0.63-1.96) | .64 |
| Navy | 1.01 (0.62-1.58) | .98 |
| No. of months in VA health care system (per 1-mo increase) | 1.004 (1.001-1.01) | .002 |
BeLPT = beryllium lymphocyte proliferation test; VA = Veterans Administration.